Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Depreciation & Amortization - Total (2018 - 2025)

Health Catalyst (HCAT) has disclosed Depreciation & Amortization - Total for 8 consecutive years, with $3.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization - Total rose 22.58% year-over-year to $3.8 million, compared with a TTM value of $14.3 million through Sep 2025, up 13.49%, and an annual FY2024 reading of $12.8 million, up 1.59% over the prior year.
  • Depreciation & Amortization - Total was $3.8 million for Q3 2025 at Health Catalyst, up from $3.6 million in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $3.8 million in Q3 2025 and bottomed at $700000.0 in Q1 2021.
  • Average Depreciation & Amortization - Total over 5 years is $2.8 million, with a median of $3.1 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization - Total soared 228.57% in 2022, then dropped 3.12% in 2023.
  • Year by year, Depreciation & Amortization - Total stood at $2.0 million in 2021, then surged by 60.0% to $3.2 million in 2022, then decreased by 3.12% to $3.1 million in 2023, then grew by 6.45% to $3.3 million in 2024, then rose by 15.15% to $3.8 million in 2025.
  • Business Quant data shows Depreciation & Amortization - Total for HCAT at $3.8 million in Q3 2025, $3.6 million in Q2 2025, and $3.6 million in Q1 2025.